(Q34745082)

4 August 2017

title

What is heartburn worth? A cost-utility analysis of management strategies (English)

1 reference

4 August 2017

G R Heudebert

1

1 reference

4 August 2017

R M Centor

2

1 reference

4 August 2017

J C Klapow

3

1 reference

4 August 2017

R Marks

4

1 reference

4 August 2017

L Johnson

5

1 reference

4 August 2017

C M Wilcox

6

1 reference

4 August 2017

publication date

1 March 2000

1 reference

Journal of General Internal Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

15

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

175-182

1 reference

Heartburn requiring frequent antacid use may indicate significant illness

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Long-term management of gastroesophageal reflux disease and its complications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

The Rationale for Continuous Maintenance Treatment of Reflux Esophagitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

7 July 2018

Heartburn--the acid test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495356

Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.02639.X

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.02639.X

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

21 January 2018

1 reference

12 December 2020

Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease

1 reference

12 December 2020

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

1 reference

12 December 2020

Evaluation of omeprazole in reflux oesophagitis

1 reference

12 December 2020

Epidemiology of oesophageal reflux disease

1 reference

12 December 2020

Symptom index as a marker of gastro-oesophageal reflux disease

1 reference

12 December 2020

Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring

1 reference

12 December 2020

Gastroesophageal reflux: what is the role of barium studies?

1 reference

12 December 2020

A comparison of five maintenance therapies for reflux esophagitis

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology

1 reference

12 December 2020

Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis

1 reference

12 December 2020

Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis

1 reference

12 December 2020

10.1046/J.1525-1497.2000.02639.X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference